Stay updated on Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Sign up to get notified when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.

Latest updates to the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedLocations section updated to add Arizona, New York, Pennsylvania, and Utah sites and remove prior location blocks. The revision is labeled v3.3.3.SummaryDifference0.6%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2; this appears to be a metadata update without substantive changes to study details.SummaryDifference0.1%

- Check52 days agoChange DetectedThe NIH funding operating status notice was removed from the page, with no impact on the core study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedNo significant changes detected between the two screenshots; the page content, including the title and key study details, appears unchanged.SummaryDifference0.5%

- Check95 days agoChange DetectedNew operating-status notice and version update to v3.2.0 are now present, replacing the previous v3.1.0; this adds important information about potential funding-related service limitations and where to check for status.SummaryDifference3%

- Check103 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Maintenance Therapy Trial: Odetiglucan & CD40 Agonist
Enter your email address, and we'll notify you when there's something new on the Maintenance Therapy Trial: Odetiglucan & CD40 Agonist page.